200 related articles for article (PubMed ID: 15003538)
1. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro.
Takaki T; Fukasawa K; Suzuki-Takahashi I; Hirai H
Biochem Biophys Res Commun; 2004 Mar; 316(1):252-5. PubMed ID: 15003538
[TBL] [Abstract][Full Text] [Related]
2. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.
Suzuki-Takahashi I; Kitagawa M; Saijo M; Higashi H; Ogino H; Matsumoto H; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 May; 10(9):1691-8. PubMed ID: 7753545
[TBL] [Abstract][Full Text] [Related]
3. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro.
Peeper DS; Keblusek P; Helin K; Toebes M; van der Eb AJ; Zantema A
Oncogene; 1995 Jan; 10(1):39-48. PubMed ID: 7824278
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile.
Kranenburg O; de Groot RP; Van der Eb AJ; Zantema A
Oncogene; 1995 Jan; 10(1):87-95. PubMed ID: 7824282
[TBL] [Abstract][Full Text] [Related]
6. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
Stiegler P; De Luca A; Bagella L; Giordano A
Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma protein recruits histone deacetylase to repress transcription.
Brehm A; Miska EA; McCance DJ; Reid JL; Bannister AJ; Kouzarides T
Nature; 1998 Feb; 391(6667):597-601. PubMed ID: 9468139
[TBL] [Abstract][Full Text] [Related]
8. Control of E2F activity by p21Waf1/Cip1.
Delavaine L; La Thangue NB
Oncogene; 1999 Sep; 18(39):5381-92. PubMed ID: 10498892
[TBL] [Abstract][Full Text] [Related]
9. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
Rubin SM; Gall AL; Zheng N; Pavletich NP
Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase-mediated phosphorylation of RBP1 and pRb promotes their dissociation to mediate release of the SAP30·mSin3·HDAC transcriptional repressor complex.
Suryadinata R; Sadowski M; Steel R; Sarcevic B
J Biol Chem; 2011 Feb; 286(7):5108-18. PubMed ID: 21148318
[TBL] [Abstract][Full Text] [Related]
11. TGFbeta-mediated formation of pRb-E2F complexes in human myeloid leukemia cells.
Hu XT
Biochem Biophys Res Commun; 2008 May; 369(2):277-80. PubMed ID: 18294958
[TBL] [Abstract][Full Text] [Related]
12. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F.
Chew YP; Ellis M; Wilkie S; Mittnacht S
Oncogene; 1998 Oct; 17(17):2177-86. PubMed ID: 9811449
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
[TBL] [Abstract][Full Text] [Related]
14. Engineered mutants of pRB with improved growth suppression potential.
Antelman D; Perry S; Hollingsworth R; Gregory RJ; Driscoll B; Fung YK; Bookstein R
Oncogene; 1997 Dec; 15(23):2855-66. PubMed ID: 9419977
[TBL] [Abstract][Full Text] [Related]
15. The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of retinoblastoma protein (pRb) and restores pRb tumor suppressive function in melanoma cells.
von Willebrand M; Zacksenhaus E; Cheng E; Glazer P; Halaban R
Cancer Res; 2003 Mar; 63(6):1420-9. PubMed ID: 12649208
[TBL] [Abstract][Full Text] [Related]
16. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
17. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H
J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression.
Frolov MV; Dyson NJ
J Cell Sci; 2004 May; 117(Pt 11):2173-81. PubMed ID: 15126619
[TBL] [Abstract][Full Text] [Related]
19. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft.
Kennedy BK; Liu OW; Dick FA; Dyson N; Harlow E; Vidal M
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8720-5. PubMed ID: 11447271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
